Several reports describe potential DYRK1A inhibitors and their possible use for correcting DS-related cognitive deficits (Duchon and Herault, 2016; de la Torre and Dierssen, 2012; Becker et al., 2014). The gene discussed is DYRK1A; the disease is Dravet syndrome.